|
PGM3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.370800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.674410E-01 |
| Normal-vs-Stage2 |
6.280200E-01 |
| Normal-vs-Stage3 |
2.026500E-02 |
| Normal-vs-Stage4 |
3.253000E-01 |
| Stage1-vs-Stage2 |
1.837630E-01 |
| Stage1-vs-Stage3 |
4.860100E-03 |
| Stage1-vs-Stage4 |
5.651900E-02 |
| Stage2-vs-Stage3 |
5.222000E-02 |
| Stage2-vs-Stage4 |
4.391600E-01 |
| Stage3-vs-Stage4 |
4.138000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.501400E-01 |
| Normal-vs-AfricanAmerican |
7.127800E-01 |
| Normal-vs-Asian |
8.141600E-01 |
| Caucasian-vs-AfricanAmerican |
7.960600E-01 |
| Caucasian-vs-Asian |
9.237800E-01 |
| AfricanAmerican-vs-Asian |
9.972200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.341000E-01 |
| Normal-vs-Female |
1.205890E-02 |
| Male-vs-Female |
5.586100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.933200E-01 |
| Normal-vs-Extreme_Weight |
1.728470E-02 |
| Normal-vs-Obese |
1.819190E-01 |
| Normal-vs-Extreme_Obese |
4.289600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.532200E-02 |
| Normal_Weight-vs-Obese |
3.320400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.484200E-01 |
| Extreme_Weight-vs-Obese |
1.564030E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.604600E-01 |
| Obese-vs-Extreme_Obese |
2.132600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.169800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.575400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.110800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.817700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.186380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.417800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.014000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.382260E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.523900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.796600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.438760E-01 |
| Normal-VS-Type2 PRCC |
1.983600E-01 |
| Normal-VS-KIRP CIMP |
1.273560E-02 |
| Normal-VS-Unclassified PRCC |
2.629200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.739900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.716100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.109600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.240300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.888200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.106000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.348800E-01 |
| Normal-vs-N1 |
3.276100E-03 |
| Normal-vs-N2 |
9.903600E-01 |
| N0-vs-N1 |
4.218800E-03 |
| N0-vs-N2 |
9.721600E-01 |
| N1-vs-N2 |
1.932370E-01 |
|
|
